The aggregation between AITD with rheumatologic, or dermatologic, autoimmune diseases

Poupak Fallahi, Giusy Elia, Francesca Ragusa, Ilaria Ruffilli, Stefania Camastra, Claudia Giusti, Sabrina Rosaria Paparo, Debora Gonnella, Yehuda Shoenfeld, Silvia Martina Ferrari, Alessandro Antonelli

Research output: Contribution to journalReview articlepeer-review


Autoimmune thyroid diseases (AITD) are organ-specific autoimmune disorders mediated by Th1 lymphocytes, whose main clinical presentations are Hashimoto's thyroiditis (HT), or Graves' disease (GD). HT, GD, thyroid autoantibodies and thyroid dysfunctions have been shown in systemic rheumatologic diseases (as Sjögren's syndrome, systemic lupus erythematosus, rheumatoid arthritis, systemic sclerosis, or cryoglobulinemia). New associations of AITD with other autoimmune diseases are being discovered, for example with psoriatic arthritis and dermatological diseases. Several investigations suggest the importance of a shared genetic susceptibility and of environmental factors in patients with AITD and associated systemic autoimmunity. A major Th1 autoimmune response occurs in the initial, and/or active phases of organ-specific autoimmune disorders and/or systemic rheumatologic diseases with increased serum, or tissue, expressions of the Th1 chemokine CXCL10. Thyroid dysfunctions might have an important clinical impact, so a periodic thyroid screening in women with systemic or dermatological autoimmunity, overall in presence of thyroid autoantibodies is suggested.

Original languageEnglish
Article number101372
JournalBest Practice and Research in Clinical Endocrinology and Metabolism
Issue number6
StatePublished - Dec 2019


  • autoimmune thyroid diseases
  • chemokines
  • cytokines
  • dermatological autoimmune diseases
  • systemic autoimmune diseases


Dive into the research topics of 'The aggregation between AITD with rheumatologic, or dermatologic, autoimmune diseases'. Together they form a unique fingerprint.

Cite this